Back to User profile » Mr Myung-chol Kang

Paper published by Mr Myung-chol Kang:


Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects

Cha YJ, Lim KS, Park MK, Schneider S, Bray B, Kang MC, Chung JY, Yoon SH, Cho JY, Yu KS

Drug Design, Development and Therapy 2014, 8:1613-1619

Published Date: 26 September 2014